This compound is primarily utilized in pharmaceutical research and development, particularly in the design and synthesis of novel drug candidates. Its structure, featuring a phenyl group and a pyrazine ring, makes it a valuable intermediate in the creation of molecules targeting neurological disorders, such as Alzheimer's disease and Parkinson's disease. The compound's chiral center allows for the exploration of enantioselective interactions with biological targets, enhancing the specificity and efficacy of potential therapeutics. Additionally, it is investigated for its potential role in modulating enzyme activity, particularly in pathways related to inflammation and oxidative stress, which are critical in various chronic diseases. Its application extends to the development of bioactive peptides and small molecules that can act as inhibitors or modulators of specific protein-protein interactions, contributing to advancements in precision medicine.